Forum Markets developing novel drugs for treating distinct inflammatory diseases.
Forum Markets has raised $10.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in March 2026.
Forum Markets's investors include Polychain, Electric Capital, GSR, Peter Thiel, Robert Leshner.
Forum Markets is headquartered in Menlo Park, United States.
Forum Markets developing novel drugs for treating distinct inflammatory diseases.
Forum Markets is at the Post-IPO Debt stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Forum Markets — Funding & Investors." VCBacked, March 9, 2026, https://www.vcbacked.co/company/forum-markets. Accessed August 14, 2026.
VCBacked. (2026). Forum Markets — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/forum-markets
{{cite web |title=Forum Markets — Funding & Investors |url=https://www.vcbacked.co/company/forum-markets |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated